EMA Authorised: Aripiprazole Accord (aripiprazole) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA authorised Aripiprazole Accord as a generic aripiprazole product for schizophrenia and bipolar disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Aripiprazole Accord (aripiprazole)

Snippet

Status: Authorised. Therapeutic area: Schizophrenia;Bipolar Disorder. MAH: Accord Healthcare S.L.U.. Decision date: 24/02/2025